Ocular Therapeutix, Inc. (OCUL)
10.44
-0.60
(-5.43%)
USD |
NASDAQ |
Mar 05, 13:45
Ocular Therapeutix Free Cash Flow : -216.89M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Abbott Laboratories | 7.395B |
| EyePoint Plc | -213.59M |
| Quince Therapeutics, Inc. | -38.98M |
| Ernexa Therapeutics, Inc. | -9.436M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -54.25M |
| Cash from Investing (Quarterly) | -2.839M |
| Cash from Financing (Quarterly) | 449.38M |
| Free Cash Flow Per Share (Quarterly) | -0.2561 |
| Free Cash Flow to Equity (Quarterly) | -57.05M |
| Free Cash Flow to Firm (Quarterly) | -54.26M |
| Free Cash Flow Yield | -11.10% |